Via Christi Regional Medical Center Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00934193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Via Christi Clinic, P.A., USA | Via Christi Regional Medical Center-St Francis Campus

Active Ingredients

Drugs in Phase 3 Trials (1)

gabapentin (neurontin) (1 trial)

Drugs in Phase 2 Trials (1)

pamrevlumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Pulmonary Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2